HEMGENIX Dinner

Join us for dinner and learn about HEMGENIX: the first and only FDA-approved gene therapy for hemophilia B. HEMGENIX is a one time gene therapy for treatment of adults with hemophilia B who currently use Factor IX prophylaxis therapy or have current or historical life-threatening bleeding or have repeated, serious spontaneous bleeding episodes.